000 01401 a2200409 4500
005 20250512064151.0
264 0 _c19871216
008 198712s 0 0 eng d
022 _a0007-1048
024 7 _a10.1111/j.1365-2141.1987.tb01338.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLane, D A
245 0 0 _aAntithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
_h[electronic resource]
260 _bBritish journal of haematology
_cAug 1987
300 _a523-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntithrombin III
_xgenetics
650 0 4 _aAntithrombin Proteins
650 0 4 _aAntithrombins
_xgenetics
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aHeparin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPedigree
650 0 4 _aThrombin
_xantagonists & inhibitors
650 0 4 _aThrombophlebitis
_xblood
700 1 _aLowe, G D
700 1 _aFlynn, A
700 1 _aThompson, E
700 1 _aIreland, H
700 1 _aErdjument, H
773 0 _tBritish journal of haematology
_gvol. 66
_gno. 4
_gp. 523-7
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.1987.tb01338.x
_zAvailable from publisher's website
999 _c3669210
_d3669210